FDA Inspection 824833 — Integrity Biosurgical Systems, Inc.
The FDA completed an inspection of Integrity Biosurgical Systems, Inc. on Mar 27, 2013 in Andover, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 27, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Andover, NJ (United States)